title: Pharmacotherapy: disparate bedfellows in a lasting drug union?
authors: Evan R
authors: ER
authors: Simpson
authors: Peter J
authors: PJ
authors: Fuller
mesh_terms: D000818:Animals; D004032:Diet; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D004958:Estradiol / Q000008:administration & dosage* / Q000009:adverse effects; D052216:Glucagon-Like Peptide 1 / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D024821:Metabolic Syndrome / Q000188:drug therapy*; D051379:Mice; D009765:Obesity / Q000188:drug therapy / Q000209:etiology / Q000378:metabolism; D015431:Weight Loss
chemical_list: D004338:Drug Combinations; D004958:Estradiol; D052216:Glucagon-Like Peptide 1
references: Am J Physiol Endocrinol Metab. 2008 May;294(5):E817-26
references: 18334610
references: Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9232-7
references: 16754860
references: JAMA. 2007 Jul 11;298(2):194-206
references: 17622601
references: J Pept Sci. 2012 Jun;18(6):383-93
references: 22565812
references: Cell Metab. 2011 Oct 5;14(4):453-65
references: 21982706
references: Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12735-40
references: 11070087
references: Mol Cell Endocrinol. 1998 Jun 25;141(1-2):179-86
references: 9723898
references: Nat Med. 2012 Dec;18(12):1847-56
references: 23142820